Evidence map›Paper›PMID 34600007›Full record

ArticleChemosphere2022

Reuse of medical face masks in domestic and community settings without sacrificing safety: Ecological and economical lessons from the Covid-19 pandemic.

Jean-Pierre Alcaraz, Laurence Le Coq, Jérémie Pourchez, Dominique Thomas, Sandrine Chazelet, Isabelle Boudry, Maud Barbado, Sophie Silvent, Claire Dessale, Fabienne Antoine and 25 more

Open access · bronzeAbstract read
In one paragraph

Article in Chemosphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 9 institutions in 1 country.

Jean-Pierre AlcarazUniv. Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000, Grenoble, France.
Laurence Le CoqIMT Atlantique, GEPEA, CNRS UMR 6144, CS 20722, 44307, Nantes, France.
Jérémie PourchezMines Saint-Etienne, Univ Lyon, Univ Jean Monnet, INSERM, U 1059 Sainbiose, Centre CIS, 42023, Saint-Etienne, France.
Dominique ThomasUniversité de Lorraine, CNRS UMR 7274 LRGP, 54001, Nancy, France.
Sandrine ChazeletINRS Département Ingénierie des Procédés, 1 rue du Morvan, CS 60027, 54519 Vandoeuvre Cedex, France.
Isabelle BoudryClinical Investigation Center-Technological Innovation 1406 (CIC-IT), Department of Public Health, Grenoble Alpes University Hospital, 38700, Grenoble, France.
Maud BarbadoClinical Investigation Center-Technological Innovation 1406 (CIC-IT), Department of Public Health, Grenoble Alpes University Hospital, 38700, Grenoble, France.
Sophie SilventClinical Investigation Center-Technological Innovation 1406 (CIC-IT), Department of Public Health, Grenoble Alpes University Hospital, 38700, Grenoble, France.
Claire DessaleCIC Inserm 1433 Innovation Technologiques, CHRU de Nancy, Université de Lorraine, 54000, Nancy, France.
Fabienne AntoineCIC Inserm 1433 Innovation Technologiques, CHRU de Nancy, Université de Lorraine, 54000, Nancy, France.
Catherine Guimier-PingaultCentre Hospitalier Universitaire Grenoble Alpes, 38700, La Tronche, France.
Laurent CortellaARC-Nucleart, CEA Grenoble, 17, rue des Martyrs, Cedex 9, 38054, Grenoble, France.
Sophie RouifIonisos SAS, 13 Chemin du Pontet, 69380, Civrieux-d'Azergues, France.
Nathalie Bardin-MonnierUniversité de Lorraine, CNRS UMR 7274 LRGP, 54001, Nancy, France.
Augustin CharvetUniversité de Lorraine, CNRS UMR 7274 LRGP, 54001, Nancy, France.
Olivier DufaudUniversité de Lorraine, CNRS UMR 7274 LRGP, 54001, Nancy, France.
Lara LeclercMines Saint-Etienne, Univ Lyon, Univ Jean Monnet, INSERM, U 1059 Sainbiose, Centre CIS, 42023, Saint-Etienne, France.
Yoann MontigaudMines Saint-Etienne, Univ Lyon, Univ Jean Monnet, INSERM, U 1059 Sainbiose, Centre CIS, 42023, Saint-Etienne, France.
Coralie LaurentMines Saint-Etienne, Univ Lyon, Univ Jean Monnet, INSERM, U 1059 Sainbiose, Centre CIS, 42023, Saint-Etienne, France.
Paul VerhoevenCIRI (Centre International de Recherche en Infectiologie), Equipe GIMAP (team 15), INSERM U1111, CNRS, ENS, UCBL1, Université Jean Monnet, Université de Lyon, 42000, Saint-Etienne, France; Service des Agents Infectieux et d'Hygiène, CHU de St-Etienne, 42000, Saint-Etienne, France.
Aurélie JoubertIMT Atlantique, GEPEA, CNRS UMR 6144, CS 20722, 44307, Nantes, France.
Ala BouhanguelIMT Atlantique, GEPEA, CNRS UMR 6144, CS 20722, 44307, Nantes, France.
Yves AndresIMT Atlantique, GEPEA, CNRS UMR 6144, CS 20722, 44307, Nantes, France.
Joël GafféUniv. Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000, Grenoble, France.
Donald K MartinUniv. Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000, Grenoble, France.
Christophe HuetCentre Hospitalier Universitaire Grenoble Alpes, 38700, La Tronche, France.
Sandrine BoissetUniv. Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000, Grenoble, France; Centre Hospitalier Universitaire Grenoble Alpes, 38700, La Tronche, France.
Max MaurinUniv. Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000, Grenoble, France; Centre Hospitalier Universitaire Grenoble Alpes, 38700, La Tronche, France.
Pascal RumeauInstitut Français Textile Et Habillement, 93 Chemin des Mouilles, 69130, Ecully, France.
Frédéric CharlotCMTC, Grenoble INP, Univ. Grenoble Alpes, 38000, Grenoble, France.
Emmanuel RichaudArts et Métiers ParisTech, Laboratoire de Procédés et Ingénierie en Mécanique et Matériaux (PIMM), CNRS, CNAM, UMR, 8006, 75013, Paris, France.
Alexandre Moreau-GaudryUniv. Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000, Grenoble, France; Clinical Investigation Center-Technological Innovation 1406 (CIC-IT), Department of Public Health, Grenoble Alpes University Hospital, 38700, Grenoble, France.
Vincent BonneterreUniv. Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000, Grenoble, France; Centre Hospitalier Universitaire Grenoble Alpes, 38700, La Tronche, France.
Philippe CinquinUniv. Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000, Grenoble, France; Centre Hospitalier Universitaire Grenoble Alpes, 38700, La Tronche, France.
Caroline LandelleUniv. Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, 38000, Grenoble, France; Centre Hospitalier Universitaire Grenoble Alpes, 38700, La Tronche, France. Electronic address: CLandelle@chu-grenoble.fr.
Centre National de la Recherche Scientifique · FRInserm · FRUniversité Claude Bernard Lyon 1 · FRInstitut polytechnique de Grenoble · FRCentre Hospitalier Universitaire de Grenoble · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRConservatoire National des Arts et Métiers · FRInstitut Français du Textile et de l'Habillement · FRInstitut National de Recherche et de Sécurité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The need for personal protective equipment increased exponentially in response to the Covid-19 pandemic. To cope with the mask shortage during springtime 2020, a French consortium was created to find ways to reuse medical and respiratory masks in healthcare departments. The consortium addressed the complex context of the balance between cleaning medical masks in a way that maintains their safety and functionality for reuse, with the environmental advantage to manage medical disposable waste despite the current mask designation as single-use by the regulatory frameworks. We report a Workflow that provides a quantitative basis to determine the safety and efficacy of a medical mask that is decontaminated for reuse. The type IIR polypropylene medical masks can be washed up to 10 times, washed 5 times and autoclaved 5 times, or washed then sterilized with radiations or ethylene oxide, without any degradation of their filtration or breathability properties. There is loss of the anti-projection properties. The Workflow rendered the medical masks to comply to the AFNOR S76-001 standard as "type 1 non-sanitory usage masks". This qualification gives a legal status to the Workflow-treated masks and allows recommendation for the reuse of washed medical masks by the general population, with the significant public health advantage of providing better protection than cloth-tissue masks. Additionally, such a legal status provides a basis to perform a clinical trial to test the masks in real conditions, with full compliance with EN 14683 norm, for collective reuse. The rational reuse of medical mask and their end-of-life management is critical, particularly in pandemic periods when decisive turns can be taken. The reuse of masks in the general population, in industries, or in hospitals (but not for surgery) has significant advantages for the management of waste without degrading the safety of individuals wearing reused masks.

Indexed as

COVID-19PandemicsHumansMasksPersonal Protective EquipmentSARS-CoV-2Covid-19FiltrationMaskPolypropyleneReuseWaste management

Identifiers

PMID34600007
PMCPMC8491628
OpenAlexW3203649468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.